Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $730.0000 (1.85%) ($730.0000 - $732.5500) on Wed. Apr. 13, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.45% (three month average) | RSI | 69 | Latest Price | $730.0000(1.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.6% a day on average for past five trading days. | Weekly Trend | REGN advances 2.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(59%) DIA(41%) IWD(39%) XLV(39%) SPLV(38%) | Factors Impacting REGN price | REGN will decline at least -0.725% in a week (0% probabilities). VIXM(-19%) TBT(-12%) UUP(-8%) VXX(-3%) USO(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.725% (StdDev 1.45%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $726.29(0.51%) | 10 Day Moving Average | $713.44(2.32%) | 20 Day Moving Average | $700.71(4.18%) | To recent high | -1.2% | To recent low | 21.1% | Market Cap | $77.401b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |